Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

Evommune Series Private Placement November 2026

funding round1 mentionslast seen Nov 4, 2026

Private placement of 4,966,889 shares at $6.04 per share for approximately $30 million.

Relationships 1

Evommune, Inc.funded byEvommune Series Private Placement November 202692% confidence1 source

Evommune Series Private Placement November 2026

Relationship

Evommune, Inc.funded byEvommune Series Private Placement November 2026

92% confidence1 supporting mentionsfrom Nov 4, 2026

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGARNov 4, 2026Evommune, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events
the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain investors (the "Investors") pursuant to which the Company, in a private placement (the "Private Placement"), agreed to issue and sell to the Investors an aggregate of 4,966,889 shares